Sickle Cell Specialist, Sickle Cell Disease; Newark

Sickle Cell Specialist, Sickle Cell Disease (Newark)

At Agios, we are fueled by connections to transform rare diseases. We foster an inclusive, collaborative culture that sparks bold thinking and strengthens our connections within the rare disease communities we serve. Our commitment is deeply personal and grounded in meaningful partnerships.

We are seeking individuals with a demonstrated track record of launching rare disease medicines and who are motivated by building durable markets in complex, underserved therapeutic areas. The Sickle Cell Specialist will help raise awareness of Sickle Cell Disease (SCD), advance disease education, and prepare the ecosystem for the long‑term impact of Mitapivat and other transformative rare genetic disease treatments.

• Own the territory business, developing and executing a long‑term market building strategy across the geography.
• Lead multi‑touch disease education engagements to advance understanding of SCD pathophysiology, disease burden, and unmet need.
• Develop an integrated plan for your territory based on deep analysis, clear prioritization, and disciplined execution.
• Work with field and marketing teams to align objectives, strategies, and communications.
• Build credible, trust‑based relationships with key customers and deepen knowledge of the sickle cell marketplace.
• Collaborate with Regional Medical Affairs and Market Access to ensure seamless coordination and timely patient support.
• Advance appropriate patients toward treatment readiness while continuously assessing performance metrics and adapting strategies.
• Develop strong internal and external relationships to enable compliant business partnerships.
• Ensure appropriate and compliant utilization of approved corporate, promotional, and other resources for customer engagements.
• Represent Agios professionally at company meetings and conferences, ensuring compliance with all laws, regulations, policies, and guidelines.
• Achieve or exceed sales forecasts and targets within budget.
• Lead ad‑hoc initiatives to contribute to business as requested.

• Priority HCPs view you as a trusted SCD partner, not just a product representative.
• Disease education conversations deepen over time and lead to earlier identification of appropriate patients.
• Accounts are prepared to act efficiently once therapy is approved for appropriate patients.
• Cross‑functional partners rely on your insights to inform strategy and execution.

• Bachelor’s degree required; scientific degree a plus.
• Proven track record of success in rare disease sales (minimum 5 years).
• Experience in Sickle Cell, Hematology, or Oncology sales is preferred.
• Experience building disease awareness and launching first‑in‑class therapies.
• Demonstrated business acumen with account management skills, data analysis, and competitive selling.
• Ability to translate complex clinical and scientific concepts into credible, compliant dialogue.
• Experience collaborating cross‑functionally with marketing, medical affairs, market access, patient services, and sales operations.
• Knowledge of payer and clinical landscape, especially in specialty and rare diseases.
• Results‑oriented mindset thriving in a fast‑paced, entrepreneurial environment.
• Ability to navigate ambiguity and drive results.
• Resourceful, self‑starter with an innovative mindset and ability to develop and execute new business solutions.
• Commitment to customer experience and standards of excellence.
• Willingness to travel extensively across large geographies.
• Established relationships with hematology/oncology HCPs within designated geography strongly preferred.
• Prior experience launching rare disease products strongly preferred.
• Experience leading regional and/or national initiatives strongly preferred.
• Experience in diseases with access challenges, health equity considerations, or historically underserved patient populations is strongly preferred.

Both virtual and in‑person meetings are facilitated as needed. The role requires an average of 50‑60% travel within the territory, focusing on the major market areas of Newark, Hackensack, New Brunswick, and…